Inhibitors of APOL1 and methods of using same
PH12023550304B1Active Publication Date: 2026-08-05VERTEX PHARMACEUTICALS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12023550304
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-02-02
- Publication Date
- 2026-08-05
- Estimated Expiration
- 2043-02-02
Abstract
The disclosure provides at least one entity chosen from compounds of Formula I, a tautomer thereof, a deuterated derivative of that compound or tautomer, and a pharmaceutically acceptable salt of any of the foregoing, compositions comprising the same, and methods of using the same, including uses in treating APOL1-mediated diseases, including pancreatic cancer, focal segmental glomerulosclerosis (FSGS), and / or non-diabetic kidney disease (NDKD).
Need to check novelty before this filing date? Find Prior Art